81273 Kit gene analys d816 variant
Also known as: KIT D816 variant analysis, GIST D816 mutation test
KIT proto-oncogene receptor tyrosine kinase (KIT) gene targeted analysis specifically for D816 variant to assess gastrointestinal stromal tumor mutations.
In Plain Language
GIST treatment planning test; Imatinib resistance detection
Clinical Context
Specifically targets KIT D816 variants associated with imatinib resistance in GIST. Important for treatment selection and predicting therapeutic response.
RVU Information
CPT 81273 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81273?
CPT 81273 (Kit gene analys d816 variant) is a Pathology & Lab code. KIT proto-oncogene receptor tyrosine kinase (KIT) gene targeted analysis specifically for D816 variant to assess gastrointestinal stromal tumor mutations.
Who uses CPT code 81273?
CPT 81273 is used by Pathology, Oncology, Gastroenterology. Specifically targets KIT D816 variants associated with imatinib resistance in GIST. Important for treatment selection and predicting therapeutic response.
When is CPT 81273 used?
Specifically targets KIT D816 variants associated with imatinib resistance in GIST. Important for treatment selection and predicting therapeutic response.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.